Global Vaccines Market Forecast 2022 – 2026| Key Players - GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Sanofi SA (France), and Pfizer, Inc. (US)

Posted September 15, 2022 by NehaSoni1234

The Global Vaccines Market is projected to reach USD 67.2 billion by 2026, at a CAGR of 10.2%. The global vaccines market (including COVID-19 vaccines) is projected to reach USD 149.2 billion by 2026 during the forecast period

COVID-19 impact on the Vaccines Market
The outbreak of the COVID-19 pandemic changed the market dynamics for the market. In recent years there was a slight decrease in the traditional vaccine market since the focus shifted from common vaccines to COVID-19 vaccines. There has been a tremendous amount of effort put into developing new treatments and vaccines to cure the infection. Within a few weeks of research, companies have started coming up with drugs and treatments to treat the infection.

Get Sample PDF @

Key Market Players:
• GlaxoSmithKline plc (UK)
• Merck & Co., Inc. (US)
• Pfizer, Inc. (US)
• Sanofi SA (France)
• CSL Limited (Australia)
• Emergent BioSolutions, Inc. (US)
• Johnson & Johnson (US)
• AstraZeneca plc (UK)
• Serum Institute of India Pvt. Ltd. (India)
• Bavarian Nordic A/S (Denmark)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Daiichi Sankyo Company, Limited (Japan)
• Panacea Biotec, Ltd. (India)

This report categorizes the vaccines market into the following segments and subsegments:

Vaccines Market, by Technology (excluding COVID 19 vaccines)
• Conjugate vaccines
• Inactivated & Subunit vaccines
• Live Attenuated vaccines
• Recombinant vaccines
• Toxoid vaccines
• Viral vector vaccines

COVID 19 Vaccines Market, by Technology
• mRNA vaccines
• Viral Vector vaccines
Other vaccines (inactivated, recombinant, conjugate, subunit, peptide, and DNA vaccines)
Vaccines Market, by Type

• Monovalent vaccines
• Multivalent vaccines

Vaccines Market, by Disease Indication
• Influenza
• Pneumococcal diseases
• Combination vaccines
• Herpes Zoster
• Meningococcal diseases
• Rotavirus
• Varicella
• Hepatitis
• Polio
• COVID 19
• Other disease indications (cancer, dengue, tuberculosis, typhoid, Japanese encephalitis, rabies, yellow fever, and allergies)

Buy Now @

Report Objectives
• To define, describe, and forecast the global vaccines market on the basis of technology, type, disease indication, route of administration, end user, and region
• To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall vaccines market
• To analyze the market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA)
• To profile the key players and comprehensively analyze their product portfolios, market shares and rankings, and core competencies
• To track and analyze competitive developments, such as acquisitions, product launches, expansions, regulatory approvals, agreements, partnerships, and collaborations in the global vaccines market

Contact Us:
• Markets and Markets
• Phone: +1-888-600-6441
• E-Mail ID: [email protected]
• Web URL:
• LinkedIn URL:
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By sales123
Phone +1-888-600-6441
Business Address pune
Country India
Categories Biotech , Health
Tags global vaccines market , global vaccines market size , global vaccines market share , global vaccines market growth , global vaccines market trends , global vaccines market analysis
Last Updated September 15, 2022